• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FFC

FARMAFORCE LIMITED

0.00% ! 6.4¢
Currently unlisted.
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
FFC
Ann: Appendix 3Y - G. Elias 		19/04/18 0 61
19/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  61 
FFC
Ann: Appendix 3Y - G. Elias 		18/04/18 0 48
18/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  48 
FFC
Ann: Change of Address 		01/03/18 0 78
01/03/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  78 
FFC
Ann: Appendix D & Interim Financial Rep - 31 December 2017 		28/02/18 0 120
28/02/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Imricor Med and Philips launch commercial iMR lab solution

Imricor Medical Systems has launched a new Interventional MR (iMR) lab solution in collaboration with Dutch company Royal Philips.
Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth Civmec has delivered FY26 revenue growth of 11.4% and a 22.5% rise in profit, with a $1.4 billion order book supporting its FY27 outlook.
Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus Askari Metals Executive Director Gino D’Anna discusses the company’s Ethiopia strategy, permitting progress, and broader portfolio ambitions.
4DMedical posts FY26 revenue growth as commercial deployment ramps up 4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Nova Minerals achieves key milestone on path to Alaskan antimony production Nova Minerals has shipped key processing and refining equipment to its Port MacKenzie plant site by barge from Seattle.

Featured News

NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.